MALORIE EVANS: Open Payments
NPI 1841672854 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,744 in 99 payments from 16 companies in 2025. Trend: 2023 $614 · 2024 $1,825 · 2025 $1,744
Food & beverage: $1,744
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 20 | $346 |
| Merck Sharp & Dohme LLC | 18 | $333 |
| AstraZeneca Pharmaceuticals LP | 9 | $184 |
| E.R. Squibb & Sons, L.L.C. | 13 | $163 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 13 | $141 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $90 |
| BridgeBio Pharma, Inc. | 4 | $88 |
| United Therapeutics Corporation | 3 | $85 |
| Actelion Pharmaceuticals US, Inc. | 3 | $82 |
| Abbott Laboratories | 3 | $49 |
Products named: WINREVAIR, AMVUTTRA, CAMZYOS, LifeVest, WAINUA, JARDIANCE, Attruby, OPSUMIT.
Industry payments across NC — which companies pay providers there.
